MMA Legislative Priorities at the Half-way Mark
March 20, 2025
With the 2025 legislative session half-over, several MMA legislative priorities appear on track for passage.
March 20, 2025
With the 2025 legislative session half-over, several MMA legislative priorities appear on track for passage.
March 20, 2025
Two months after the start of the session, all 201 legislative seats are finally filled.
March 13, 2025
Residents at Hennepin Healthcare filed for union recognition on March 12, saying that they are understaffed and underpaid, among other concerns, according to a report by KARE-TV.
March 13, 2025
Legislation to limit mid-year formularies, an MMA priority, was heard in the Senate Commerce and Consumer Protection Committee on March 11.
March 13, 2025
Legislation that would reinstate non-compete clauses has returned to St. Paul.
March 13, 2025
On March 11, the House Health Finance and Policy Committee heard legislation to authorize a non-opioid directive that would include instructions to health professionals that a patient must not be administered an opioid or be offered a prescription for an opioid, if they so choose.
March 13, 2025
Minnesota is regularly awarded with state innovation waivers from the U.S. Department of Health and Human Services for its Premium Security Plan, a program designed to reduce premiums for residents who buy their insurance on the individual marketplace.
March 13, 2025
On March 31, State Sen. Erin Maye Quade (DFL-Apple Valley) will meet with the Minnesota Health Equity Community of Practice (CoP) via Zoom from noon to 1 pm, to present legislative updates and priorities relevant to heath equity. Her presentation will include a Q & A session.
March 6, 2025
A bill to improve maternal mental health services by requiring health plans to reimburse for services to provide comprehensive mental health services for pregnant and postpartum individuals was heard in the Senate Commerce and Consumer Protection Committee this week.
March 6, 2025
A bill that would prohibit prior authorization (PA) for medications on certain cancer treatments has been introduced in the Senate.